Present invention relates to a stable solid oral composition comprising (a) Ivabradine or pharmaceutically acceptable salt thereof, optionally one or more pharmaceutical excipient(s) and (b) inert granules comprising one or more diluent, one or more cellulosic binder and optionally one or more pharmaceutical excipient(s), wherein said inert granules are substantially free of Ivabradine or pharmaceutically acceptable salt thereof.